{
    "2019-10-22": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "CEO",
                        "Baby Powder",
                        "FDA",
                        "bombshell"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-07-15",
                "original_text": "7 Safe Stocks to Buy and Hold Through 2020",
                "features": {
                    "keywords": [
                        "Safe Stocks",
                        "Buy",
                        "Hold",
                        "2020"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-23",
                "original_text": "Drug/Biotech Stock Q3 Earnings on Oct 23: LLY, ALXN & More",
                "features": {
                    "keywords": [
                        "Drug/Biotech",
                        "Q3 Earnings",
                        "LLY",
                        "ALXN"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-23",
                "original_text": "Medical Products' Earnings Roster for Oct 23: TMO, BSX & More",
                "features": {
                    "keywords": [
                        "Medical Products",
                        "Earnings",
                        "TMO",
                        "BSX"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-10",
                "original_text": "Drug companies eye deals as lawsuits pile up",
                "features": {
                    "keywords": [
                        "Drug companies",
                        "deals",
                        "lawsuits"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-23",
                "original_text": "Biogen (BIIB) Beats on Q3 Earnings, Eyes FDA Nod for Aducanumab",
                "features": {
                    "keywords": [
                        "Biogen",
                        "BIIB",
                        "Q3 Earnings",
                        "FDA",
                        "Aducanumab"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}